Ropivacaine shortage — NZ supply status & alternatives

Ropivacaine

—

🇦🇺 AUST R 186569 · Boucher & Muir Pty Ltd

In supply · Australia

mixed presentations

In supply · 🇦🇺 Australia · short in🇳🇿 NZ🇳🇱 NL

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Ropivacaine
Brand names	mixed presentations
Therapeutic category	Auto-created by Pharmac — New Zealand Medicine Supply Disruptions scraper

Controlled substance	No

Marketing-authorisation holders	Boucher & Muir Pty Ltd, B BRAUN MELSUNGEN AG, SANDOZ LIMITED, ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI SPA +5 more

Registrations on file	22

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

3 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

High concentration risk

Navinta LLCChemwerth INCFine Chemicals Corp Pty LTD

Manufacturing countries: United States, China, South Africa · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 9 MA holders

Product	Strength	Form	Market	MA holder	Status
ROPIBAM 0.75% Ropivacaine hydrochloride	0.75%	—	🇦🇺 AU	Boucher & Muir Pty Ltd	Active
ROPIBAM 0.2% Ropivacaine hydrochloride	0.2%	—	🇦🇺 AU	Boucher & Muir Pty Ltd	Active
Ropivacaine Hydrochloride	2 MG	injection	🇬🇧 GB	B BRAUN MELSUNGEN AG	Active
ROPIVACAINE 2 MG/ML SOLUTION FOR INFUSION	2 MG	solution	🇬🇧 GB	SANDOZ LIMITED	Active
Ropivacaine Hydrochloride	2MG	injection	🇬🇧 GB	SANDOZ LIMITED	Active
Ropivacaine Hydrochloride	7.5MG	injection	🇬🇧 GB	SANDOZ LIMITED	Active
Ropivacaine Hydrochloride	10MG	injection	🇬🇧 GB	SANDOZ LIMITED	Active
Ropivacaine Villerton	2 MG	solution	🇬🇧 GB	ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI SPA	Active
ROPIVACAINE 2 MG/ML SOLUTION FOR INJECTION	2 MG	injection	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
ROPIVACAINE 7.5 MG/ML SOLUTION FOR INJECTION	7.5 MG	injection	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
ROPIVACAINE 10 MG/ML SOLUTION FOR INJECTION	10 MG	injection	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
ROPIVACAINE 2 MG/ML SOLUTION FOR INFUSION IN ADMINISTRATION SYSTEM	2 MG	solution	🇬🇧 GB	BIOQ PHARMA LIMITED	Active
Ropivacaine Altan	2 MG	solution	🇬🇧 GB	ALTAN PHARMACEUTICALS SA	Active
Ropivacaine Altan	7.5 MG	injection	🇬🇧 GB	ALTAN PHARMACEUTICALS SA	Active
Ropivacaine Altan	10 MG	injection	🇬🇧 GB	ALTAN PHARMACEUTICALS SA	Active

+7 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.